RecruitingNot Applicable

Biliary Fistulas in Surgery of Liver Echinococcosis

Uzbekistan200 participantsStarted 2023-10-22

Plain-language summary

The objective of the study is to improving the results of surgical treatment of liver echinococcosis complicated by biliary fistula by optimizing diagnostic approaches to early verification of this complication and improving the tactical and technical aspects of its elimination.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age under 18 years; * Informed consent for inclusion in the study; * The presence of liver echinococcosis, for which conservative surgical treatment will be performed; * The presence of the entire spectrum of necessary preoperative diagnostic measures; * A full description of all stages of surgical intervention, indicating the type of intervention (open or laparoscopic surgery, location and size of the echinococcal cyst in the liver, type of antiparasitic treatment, presence or absence of a biliary fistula in the residual cavity, actions taken in relation to the fistula, the option of eliminating the residual cavity and drainage; * Availability of objective data on the characteristics of the postoperative course, including dynamic indicators of the patient\&#39;s condition, temperature, amount and nature of discharge through the drainage, the time of drainage removal, the type of complications (if any) and the method of their treatment, the duration of the hospital period, data on the characteristics of the posthospital period up to 3 months of observation; * Absence of concomitant pathology that may affect the outcome of the surgery. Exclusion Criteria: * Age under 18 years; * Refusal to participate in the study; * Extrahepatic echinococcosis without liver damage; * Absence of the full range of preoperative diagnostic data; * Difficulties with objective analysis of the features of the performed surgical treatment; * Incomplete data on monitoring …

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Measuring the incidence of bile leakage after conservative surgical interventions for liver echinococcosis

Timeframe: 3 months

Measuring the time of closure of biliary fistulas in the postoperative period

Timeframe: 3 months

Trial details

NCT IDNCT06612229

SponsorRepublican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-09-22

View on ClinicalTrials.gov More Echinococcosis, Hepatic trials

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.